473
Views
24
CrossRef citations to date
0
Altmetric
Review

Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation

, , &
Pages 135-147 | Received 24 Nov 2016, Accepted 12 Jan 2017, Published online: 21 Jan 2017

References

  • Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011.
  • Gargiulo G, Sannino A, Capodanno D, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a systematic review and meta-analysis. Ann Intern Med. 2016;165:334–344.
  • van der Boon RM, Nuis RJ, van Mieghem NM, et al. New conduction abnormalities after TAVI–frequency and causes. Nat Rev Cardiol. 2012;9:454–463.
  • Roten L, Meier B. Left bundle branch block after transcatheter aortic valve implantation: still a matter of concern? JACC Cardiovasc Interv. 2014;7:137–139.
  • Piazza N, de Jaegere P, Schultz C, et al. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008;1:74–81.
  • Tawara S. Das reizleitungssystem de saugetierherzens: eine anatomich hisologische studie uber das atrioventricularbundel und die purkinjeschen faden. Jena, Germany: Verlag von Gustav Fischer; 1906.
  • Barbanti M, Leipsic J, Binder R, et al. Underexpansion and ad hoc post-dilation in selected patients undergoing balloon-expandable transcatheter aortic valve replacement. J Am Coll Cardiol. 2014;63:976–981.
  • Moreno R, Dobarro D, Lopez de Sa E, et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation. 2009;120:e29–e30.
  • Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3:524–530.
  • Schroeter T, Linke A, Haensig M, et al. Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace. 2012;14:1759–1763.
  • Tzamtzis S, Viquerat J, Yap J, et al. Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys. 2013;35:125–130.
  • Buellesfeld L, Stortecky S, Kalesan B, et al. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2013;6:72–83.
  • Breithardt G, Breithardt OA. Left bundle branch block, an old-new entity. J Cardiovasc Transl Res. 2012;5:107–116.
  • Koos R, Mahnken AH, Aktug O, et al. Electrocardiographic and imaging predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. J Heart Valve Dis. 2011;20:83–90.
  • Liang M, Devlin G, Pasupati S. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves. J Invasive Cardiol. 2012;24:173–176.
  • Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008;1:310–316.
  • Roten L, Wenaweser P, Delacretaz E, et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol. 2010;106:1473–1480.
  • Piazza N, Nuis RJ, Tzikas A, et al. Persistent conduction abnormalities and requirements for pacemaking 6 months after transcatheter aortic valve implantation. Eurointervention. 2010;6:475–484.
  • Urena M, Webb JG, Cheema A, et al. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2014;7:128–136.
  • Franzoni I, Latib A, Maisano F, et al. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol. 2013;112:554–559.
  • Aktug O, Dohmen G, Brehmer K, et al. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation. Int J Cardiol. 2012;160:26–30.
  • Bax JJ, Delgado V, Bapat V, et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J. 2014;35:2639–2654.
  • Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64:129–140.
  • Kempfert J, Treede H, Rastan AJ, et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA): 6-month outcomes. Eur J Cardiothorac Surg. 2013;43:52–56.
  • Seiffert M, Conradi L, Kloth B, et al. Single-centre experience with next-generation devices for transapical aortic valve implantation. Eur J Cardiothorac Surg. 2015;47:39–45.
  • Maeda K, Kuratani T, Torikai K, et al. New self-expanding transcatheter aortic valve device for transfemoral implantation- early results of the First-in-Asia Implantation of the ACURATE Neo/TF(TM) system. Circ J. 2015;79:1037–1043.
  • Schofer J, Colombo A, Klugmann S, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63:763–768.
  • Treede H, Tubler T, Reichenspurner H, et al. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J Thorac Cardiovasc Surg. 2010;140:897–903.
  • Webb J, Gerosa G, Lefevre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64:2235–2243.
  • Treede H, Mohr FW, Baldus S, et al. Transapical transcatheter aortic valve implantation using the JenaValve system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg. 2012;41:e131–e138.
  • Meredith IT, Worthley SG, Whitbourn RJ, et al. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study. EuroIntervention. 2014;9:1264–1270.
  • Meredith IT, Walters DL, Dumonteil N, et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014;64:1339–1348.
  • Gooley RP, Talman AH, Cameron JD, et al. Comparison of self-expanding and mechanically expanded transcatheter aortic valve prostheses. JACC Cardiovasc Interv. 2015;8:962–971.
  • Wohrle J, Gonska B, Rodewald C, et al. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve. Int J Cardiol. 2015;195:171–175.
  • Willson AB, Rodes-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude medical portico valve: first-in-human experience. J Am Coll Cardiol. 2012;60:581–586.
  • Kalavrouziotis D, Li D, Buth KJ, et al. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study. J Cardiothorac Surg. 2009;4:32.
  • Khatri PJ, Webb JG, Rodés-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med. 2013;158:35–46.
  • Erkapic D, de Rosa S, Kelava A,L, et al. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23:391–397.
  • Abdel-Wahab M, Mehilli J, Frerker C, et al.; CHOICE investigators. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–1514.
  • Petronio AS, Sinning JM, van Mieghem N, et al. Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the Medtronic CoreValve system: the CoreValve prospective, international, post-market ADVANCE-II study. JACC Cardiovasc Interv. 2015;8:837–846.
  • Martinez-Selles M, Gomez Doblas JJ, Carro Hevia A, et al. Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention. J Intern Med. 2014;275:608–620.
  • Ohno Y, Tamburino C, Barbanti M. Transcatheter Aortic Valve implantation experience with SAPIEN 3. Minerva Cardioangiol. 2015;63:205–216.
  • Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8:1359–1367.
  • Sinning JM, Werner N, Nickenig G, et al. Next-generation transcatheter heart valves: current trials in Europe and the USA. Methodist Debakey Cardiovasc J. 2012;8:9–12.
  • Schofer J, Schluter M, Treede H, et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ Cardiovasc Interv. 2008;1:126–133.
  • Zembala MO, Piegza J, Waclawski J, et al. Symetis acurate transapical Aortic Valve: the initial experience with a second generation of transcatheter aortic valve replacement device. Kardiol Pol. 2014;72:187–193.
  • Baan J Jr, Yong ZY, Koch KT, et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J. 2010;159:497–503.
  • Mouillet G, Lellouche N, Lim P, et al. Patients without prolonged QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block. Catheter Cardiovasc Interv. 2013;81:882–887.
  • Saia F, Lemos PA, Bordoni B, et al. Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. Catheter Cardiovasc Interv. 2012;79:712–719.
  • Toutouzas K, Synetos A, Tousoulis D, et al. Predictors for permanent pacemaker implantation after core valve implantation in patients without preexisting ECG conduction disturbances: the role of a new echocardiographic index. Int J Cardiol. 2014;172:601–603.
  • Ferreira ND, Caeiro D, Adao L, et al. Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol. 2010;33:1364–1372.
  • Gutierrez M, Rodes-Cabau J, Bagur R, et al. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J. 2009;158:302–308.
  • Houthuizen P, van Garsse LA, Poels TT, et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation. 2012;126:720–728.
  • Grube E, Naber C, Abizaid A, et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv. 2011;4:751–757.
  • Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014;129:1233–1243.
  • Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER trial and registry. JACC Cardiovasc Interv. 2015;8:60–69.
  • Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15:1070–1118.
  • Biner S, Michowitz Y, Leshem-Rubinow E, et al. Hemodynamic impact and outcome of permanent pacemaker implantation following transcatheter aortic valve implantation. Am J Cardiol. 2014;113:132–137.
  • Barbanti M, Capranzano P, Ohno Y, et al. Early discharge after transfemoral transcatheter aortic valve implantation. Heart. 2015;101:1485–1490.
  • Urena M, Hayek S, Cheema AN, et al. Arrhythmia burden in elderly patients with severe aortic stenosis as determined by continuous electrocardiographic recording: toward a better understanding of arrhythmic events after transcatheter. aortic valve replacement. Circulation. 2015;131:469–477.
  • Schwerg M, Baldenhofer G, Dreger H, et al. Complete atrioventricular block after TAVI: when is pacemaker implantation safe? Pacing Clin Electrophysiol. 2013;36:898–903.
  • Testa L, Latib A, de Marco F, et al. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve revalving system. Circulation. 2013;127:1300–1307.
  • Nazif TN, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2013;35:1599–1607.
  • Urena M, Webb JG, Eltchaninoff H, et al. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. J Am Coll Cardiol. 2015;65:437–448.
  • Orlando R, Pennant M, Rooney S, et al. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol Assess. 2013;17:1–86.
  • Naber CTM, Bramlage P, Wasem J. The impact of TAVI related permanent pacemaker implantation on the German healthcare system. Eurointervention. 2014;14A-OP319.
  • Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI Registry. J Am Coll Cardiol. 2011;58:2130–2138.
  • Elmariah S, Palacios IF, McAndrew T, et al. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the placement of aortic. Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv. 2013;6:604–614.
  • Tzikas A, Van Dalen BM, van Mieghem NM, et al. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol. 2011;107:285–289.
  • Hoffmann R, Herpertz R, Lotfipour S, et al. Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. JACC Cardiovasc Interv. 2012;5:1257–1263.
  • Carrabba N, Valenti R, Migliorini A, et al. Impact on left ventricular function and remodeling and on 1-year outcome in patients with left bundle branch block after transcatheter aortic valve implantation. Am J Cardiol. 2015;116:125–131.
  • Ando T, Takagi H; for the ALICE Group. The prognostic impact of new-onset persistent left bundle branch block following transcatheter Aortic Valve implantation: a meta-analysis. Clin Cardiol. 2016;39:544–550.
  • Pereira E, Ferreira N, Caeiro D, et al. Transcatheter aortic valve implantation and requirements of pacing over time. Pacing Clin Electrophysiol. 2013;36:559–569.
  • Buellesfeld L, Stortecky S, Heg D, et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60:493–501.
  • Mukherjee C, Busse H, Mende M, et al. Incidence and outcome of artioventricular block after transcatheter aortic valve implantation (TAVI): analysis in 994 patients. In: EACTA. 2013. p. 139–140.
  • Jilaihawi H, Chakravarty T, Weiss RE, et al. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv. 2012;80:128–138.
  • Onorati F, D’Errigo P, Barbanti M, et al. Results differ between transaortic and open surgical aortic valve replacement in women. Ann Thorac Surg. 2013;96:1336–1342.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.